BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 28109674)

  • 1. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
    Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
    Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
    PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a robotic system for irreversible electroporation (IRE) of malignant liver tumors: initial results.
    Beyer LP; Pregler B; Michalik K; Niessen C; Dollinger M; Müller M; Schlitt HJ; Stroszczynski C; Wiggermann P
    Int J Comput Assist Radiol Surg; 2017 May; 12(5):803-809. PubMed ID: 27653615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC).
    Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC
    HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
    Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
    J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma.
    Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L
    Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
    Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
    BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation Zone Involution of Liver Tumors Is Faster in Patients Treated with Irreversible Electroporation Than Microwave Ablation.
    Ridouani F; Ghosn M; Cornelis F; Petre EN; Hsu M; Moskowitz CS; Kingham PT; Solomon SB; Srimathveeravalli G
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577800
    [No Abstract]   [Full Text] [Related]  

  • 13. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
    Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
    J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
    Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible Electroporation for Colorectal Liver Metastases.
    Scheffer HJ; Melenhorst MC; Echenique AM; Nielsen K; van Tilborg AA; van den Bos W; Vroomen LG; van den Tol PM; Meijerink MR
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):159-69. PubMed ID: 26365546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
    Cheng RG; Bhattacharya R; Yeh MM; Padia SA
    J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar complication rates for irreversible electroporation and thermal ablation in patients with hepatocellular tumors.
    Verloh N; Jensch I; Lürken L; Haimerl M; Dollinger M; Renner P; Wiggermann P; Werner JM; Zeman F; Stroszczynski C; Beyer LP
    Radiol Oncol; 2019 Mar; 53(1):116-122. PubMed ID: 30840591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan.
    Sugimoto K; Moriyasu F; Kobayashi Y; Saito K; Takeuchi H; Ogawa S; Ando M; Sano T; Mori T; Furuichi Y; Nakamura I
    Jpn J Radiol; 2015 Jul; 33(7):424-32. PubMed ID: 26032929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.